Sub-optimal gain in vision in retinal vein occlusion due to under-treatment in the real world: results from an open-label prospective study of Intravitreal Ranibizumab

Peer Review reports

Original Submission
16 Sep 2020	Submitted	Original manuscript
8 Oct 2020	Reviewed	Reviewer Report
9 Oct 2020	Reviewed	Reviewer Report
5 Nov 2020	Author responded	Author comments - Raja Narayanan
Resubmission - Version 2
5 Nov 2020	Submitted	Manuscript version 2
24 Nov 2020	Reviewed	Reviewer Report
30 Nov 2020	Reviewed	Reviewer Report
2 Dec 2020	Author responded	Author comments - Raja Narayanan
Resubmission - Version 3
2 Dec 2020	Submitted	Manuscript version 3
Publishing
4 Dec 2020	Editorially accepted
12 Jan 2021	Article published	10.1186/s12886-020-01757-7

Back to article page